Nemolizumab Shows Lasting Benefits in Prurigo Nodularis ...Middle East

Medscape - News
Nemolizumab Shows Lasting Benefits in Prurigo Nodularis
Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a Japanese trial. Medscape Medical News

Hence then, the article about nemolizumab shows lasting benefits in prurigo nodularis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nemolizumab Shows Lasting Benefits in Prurigo Nodularis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News